179 related articles for article (PubMed ID: 7837915)
61. RhoC GTPase expression as a potential marker of lymph node metastasis in squamous cell carcinomas of the head and neck.
Kleer CG; Teknos TN; Islam M; Marcus B; Lee JS; Pan Q; Merajver SD
Clin Cancer Res; 2006 Aug; 12(15):4485-90. PubMed ID: 16899593
[TBL] [Abstract][Full Text] [Related]
62. [Determination of plasminogen activator of the head and neck tumor tissue].
Ji X; Nong H; Huang G
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1994; 29(5):299-301. PubMed ID: 7718296
[TBL] [Abstract][Full Text] [Related]
63. Increased PGE2 levels in nonmalignant mucosa adjacent to squamous cell carcinoma of the head and neck.
Schuon R; Brieger J; Franke RL; Jakob R; Mann WJ
ORL J Otorhinolaryngol Relat Spec; 2005; 67(2):96-100. PubMed ID: 15821352
[TBL] [Abstract][Full Text] [Related]
64. [Expression of heparanase on the squamous cell carcinoma of head and neck and its clinical significance].
Ma JG; Zhang Y; Li XM; Ren XM; Jiang XX; Wang YX
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Jan; 43(1):41-5. PubMed ID: 18357711
[TBL] [Abstract][Full Text] [Related]
65. [Malignant cervical adenopathies].
Bertrand JC; Szpirglas H
Actual Odontostomatol (Paris); 1982; 36(137):59-64. PubMed ID: 7102435
[No Abstract] [Full Text] [Related]
66. The relationship of circulating IgA to cellular immunity in head and neck cancer patients.
Schantz SP; Liu FJ; Taylor D; Beddingfield N; Weber RS
Laryngoscope; 1988 Jun; 98(6 Pt 1):671-8. PubMed ID: 3259661
[TBL] [Abstract][Full Text] [Related]
67. Prostaglandin E2 regulates gingival mononuclear cell immunoglobulin production.
Harrell JC; Stein SH
J Periodontol; 1995 Mar; 66(3):222-7. PubMed ID: 7776168
[TBL] [Abstract][Full Text] [Related]
68. Foxp3 expression in lymph node metastases in patients with head and neck cancer.
Boduc M; Roessler M; Mandic R; Netzer C; Güldner C; Walliczek-Dworschak U; Stuck BA; Mandapathil M
Acta Otolaryngol; 2017 Nov; 137(11):1215-1219. PubMed ID: 28741409
[TBL] [Abstract][Full Text] [Related]
69. Neck node immunoreactivity in head and neck carcinoma.
Mandell-Brown M; Johnson JT; Rabin BS; Hamill E; Wagner RL
Otolaryngol Head Neck Surg; 1986 Nov; 95(4):500-6. PubMed ID: 2952933
[TBL] [Abstract][Full Text] [Related]
70. CD73 expression in lymph node metastases in patients with head and neck cancer.
Mandapathil M; Boduc M; Netzer C; Güldner C; Roessler M; Wallicek-Dworschak U; Jahns E; Stuck B
Acta Otolaryngol; 2018 Feb; 138(2):180-184. PubMed ID: 28938850
[TBL] [Abstract][Full Text] [Related]
71. [Significance of panendoscopy in the search for the primary tumor in neck metastases].
Geyer G; Wisser G
Laryngol Rhinol Otol (Stuttg); 1983 Aug; 62(8):359-62. PubMed ID: 6633092
[TBL] [Abstract][Full Text] [Related]
72. Specific lymphokine responses in cervical nodes of patients with laryngeal cancer.
Cortesina G; Beatrice F; Morra B; Barioglio MG; Poggio E; Bussi M; DiFortunato V; Sacchi M; Rendine S; Sartoris A
Laryngoscope; 1987 Jul; 97(7 Pt 1):843-7. PubMed ID: 3298902
[TBL] [Abstract][Full Text] [Related]
73. The presence of circulating tumor cells (CTCs) correlates with lymph node metastasis in nonresectable squamous cell carcinoma of the head and neck region (SCCHN).
Hristozova T; Konschak R; Stromberger C; Fusi A; Liu Z; Weichert W; Stenzinger A; Budach V; Keilholz U; Tinhofer I
Ann Oncol; 2011 Aug; 22(8):1878-85. PubMed ID: 21525401
[TBL] [Abstract][Full Text] [Related]
74. Tumor infiltrating lymphocytes in squamous cell carcinoma of the head and neck: mechanisms of enhancement using prostaglandin synthetase inhibitors.
Cross DS; Platt JL; Juhn SK; Bach FH; Adams GL
Adv Exp Med Biol; 1997; 400B():1013-24. PubMed ID: 9547657
[TBL] [Abstract][Full Text] [Related]
75. Production of prostaglandin E2 by tumor cells in vitro.
Owen K; Gomolka D; Droller MJ
Cancer Res; 1980 Sep; 40(9):3167-71. PubMed ID: 7427935
[TBL] [Abstract][Full Text] [Related]
76. Variability of the thymidine labeling index in squamous cell carcinoma of the head and neck.
Greenberg B; Woo L; Blatchford S; Aguirre M; Garewal H
Laryngoscope; 1988 Jun; 98(6 Pt 1):668-70. PubMed ID: 3374244
[TBL] [Abstract][Full Text] [Related]
77. [Effects of cytokine on expression of tumor antigen TA-4 in squamous cell carcinoma].
Kobayashi M
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Apr; 41(4):412-8. PubMed ID: 2746067
[TBL] [Abstract][Full Text] [Related]
78. Prostaglandin E2 of the upper aerodigestive tract.
Johnson JT; Rabin BS; Wagner RL
Ann Otol Rhinol Laryngol; 1987; 96(2 Pt 1):213-6. PubMed ID: 3471170
[TBL] [Abstract][Full Text] [Related]
79. Expression of A9 antigen and loss of blood group antigens as determinants of survival in patients with head and neck squamous carcinoma.
Carey TE; Wolf GT; Hsu S; Poore J; Peterson K; McClatchey KD
Otolaryngol Head Neck Surg; 1987 Mar; 96(3):221-30. PubMed ID: 3108804
[TBL] [Abstract][Full Text] [Related]
80. Patterns and mechanisms of localized bone invasion by tumors: studies with squamous carcinomas of the head and neck.
Carter RL
Crit Rev Clin Lab Sci; 1985; 22(3):275-315. PubMed ID: 3899510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
